Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Sycrest“
Suchtreffer
Begriffe & Kennungen
Sycrest · 4.8 · In a 3-week, placebo-controlled, randomized, fixed-dose efficacy and safety trial in paediatric patients 10 to
Eintrag öffnenSycrest · 4.8 · In a 3-week, placebo-controlled, randomized, fixed-dose efficacy and safety trial in paediatric patients 10 to
Eintrag öffnenSycrest · 4.8 · Orthostatic hypotension The incidence of orthostatic hypotension in elderly subjects was 4.1 % compared to 0.3
Eintrag öffnenSycrest · 4.8 · Orthostatic hypotension The incidence of orthostatic hypotension in elderly subjects was 4.1 % compared to 0.3
Eintrag öffnenSycrest · 4.8 · Paediatric population Asenapine is not indicated for the treatment of children and adolescent patients below 1
Eintrag öffnenSycrest · 4.8 · Paediatric population Asenapine is not indicated for the treatment of children and adolescent patients below 1
Eintrag öffnenSycrest · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenSycrest · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenSycrest · 4.8 · Summary of safety profile The most frequently reported adverse drug reactions (ADRs) associated with the use o
Eintrag öffnenSycrest · 4.8 · Summary of safety profile The most frequently reported adverse drug reactions (ADRs) associated with the use o
Eintrag öffnenSycrest · 4.8 · System organ Very Common Uncommon Rare Not class common known Blood and Neutropenia lymphatic disorders Immune
Eintrag öffnenSycrest · 4.8 · System organ Very Common Uncommon Rare Not class common known Blood and Neutropenia lymphatic disorders Immune
Eintrag öffnenSycrest · 4.8 · Tabulated list of adverse reactions The incidences of the ADRs associated with asenapine therapy are tabulated
Eintrag öffnenSycrest · 4.8 · Tabulated list of adverse reactions The incidences of the ADRs associated with asenapine therapy are tabulated
Eintrag öffnenSycrest · 4.8 · The clinically relevant adverse experiences identified in the paediatric bipolar and schizophrenia trials were
Eintrag öffnenSycrest · 4.8 · The clinically relevant adverse experiences identified in the paediatric bipolar and schizophrenia trials were
Eintrag öffnenSycrest · 4.8 · The most common adverse reactions (proportion of patients 5 % and at least twice placebo) reported in paedia
Eintrag öffnenSycrest · 4.8 · The most common adverse reactions (proportion of patients 5 % and at least twice placebo) reported in paedia
Eintrag öffnenSycrest · 4.8 · The most common adverse reactions (≥ 5 % and at least twice the rate of placebo) reported in paediatric patien
Eintrag öffnenSycrest · 4.8 · The most common adverse reactions (≥ 5 % and at least twice the rate of placebo) reported in paediatric patien
Eintrag öffnen